Glatopa is an FDA-approved generic substitute for COPAXONE® (glatiramer acetate injection).2 This means that Glatopa:
The difference with Glatopa is that it costs a lot less.3
Glatopa 20 mg/mL is taken once a day, and has been prescribed for nearly 30,000 people since 20151,4
Glatopa 40 mg/mL is taken 3 times a week, giving you more injection-free days (209 less injections each year!)4
GlatopaCare® is a free program that connects you and your family to one-on-one support. Here’s how your GlatopaCare® team can help.
See if you're eligible* for a $0 co-pay on your monthly Glatopa prescriptions
Learn more about what your insurance and benefits may cover
Connect to nurse support anytime, day or night
Get injection training in your home or over the phone
*Glatopa Co-Pay Program Eligibility
The Glatopa Co-Pay Program provides up to $9000 in annual co-pay support for Glatopa prescriptions. This program is not health insurance. This program is for insured patients only; uninsured cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Card may not be combined with any other rebate, coupon, or offer. Card has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.
Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.
Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your healthcare provider right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your healthcare provider tells you to begin again.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your healthcare provider if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your healthcare provider of any skin changes.
Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.
The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your healthcare provider or pharmacist. Tell your healthcare provider about any side effects you have while taking Glatopa.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information for Glatopa.
1. Data on file [IMS SMART data]. Princeton, NJ: Sandoz Inc; 2020 2. U.S. Department of Health Services. Orange Book: Approved drug products with therapeutic equivalence evaluations. https://www.fda.gov/media/71474/download. Accessed November 29, 2021. 3. Data on file. Red Book. Sandoz Inc. January 2022. 4. Glatopa Prescribing Information. Sandoz Inc. April 2022.